RT Journal Article
SR Electronic
T1 Measuring Frailty Using Self-Report or Automated Tools to Identify Risk of Cardiovascular Events and Mortality: The Million Veteran Program
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.10.18.23297231
DO 10.1101/2023.10.18.23297231
A1 Qazi, Saadia
A1 Seligman, Benjamin
A1 Preis, Sarah R.
A1 Rane, Manas
A1 Djousse, Luc
A1 Gagnon, David R.
A1 Wilson, Peter W.F.
A1 Gaziano, J. Michael
A1 Driver, Jane A.
A1 Cho, Kelly
A1 Orkaby, Ariela R.
A1 MVP
YR 2023
UL http://medrxiv.org/content/early/2023/10/24/2023.10.18.23297231.abstract
AB Background Frailty, a syndrome of physiologic vulnerability, increases cardiovascular disease (CVD) risk. Whether in person or automated frailty tools are ideal for identifying CVD risk remains unclear. We calculated three distinct frailty scores and examined their associations with mortality and CVD events in the Million Veteran Program (MVP).Methods MVP is a prospective cohort of U.S. Veterans that has enrolled nearly one million Veterans. We included participants aged ≥50 years who enrolled from 2011-2018. Frailty was calculated using three tools: two frailty indices (FI) based on the accumulation of deficits theory, the 36-item MVP-FI using self-reported answers to questionaries, and the 31-item VA-FI developed using claims data. Finally, we calculated the 3-item Study of Osteoporotic Fractures Fried physical frailty score from self-report. The primary outcomes were CVD and all-cause mortality. Multivariable-adjusted Cox proportional hazards models (adjusted for age, sex, smoking, statin use, antihypertensive use, hyperlipidemia, and survey year). Secondary outcomes were myocardial infarction (MI), stroke, and heart failure (HF).Results Among 190,688 MVP participants (mean age 69 ±9 years, 94% male, 85% white), there were 33,233 (17%) all-cause and 10,115 (5%) CVD deaths. Using MVP-FI, 29% were robust, 42% pre-frail, and 29% frail. Frailty prevalence increased by age group, from 27% in 50–59-year-olds to 42% in age≥90 years. Follow-up duration was 6±2 years. Using the MVP-FI, pre-frail and frail Veterans had a higher incidence of both all-cause mortality (pre-frail: HR=1.66, 95%CI: 1.61-1.72; frail: 3.05, 2.95-3.16) and CVD death (pre-frail: 1.76, 1.65-1.88; frail: 3.65, 3.43-3.90), as compared to robust individuals. These findings remained significant among Veterans ≥ 50 years. Findings were similar for CVD events. When frailty was measured using the VA-FI and SOF results were concordant.Conclusion Irrespective of frailty measure used, frailty is associated with a higher risk of all-cause mortality and CVD events. Further study of frailty in individuals <60 years old is warranted.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported using resources and facilities of the Department of Veterans Affairs (VA) Informatics and Computing Infrastructure (VINCI), VA HSR RES 13-457. This work was supported by VA CSRD CDA2 IK2CX001800-01A1. This publication does not represent the views of the Department of Veterans Affairs or the US government.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the VA Central Office Institutional Review Board (IRB) in Washington, DC. A waiver for patient consent was obtained from the VA Boston Healthcare system IRB.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData are available to approved investigators per VA IRB rules and regulations.(CVD)Cardiovascular disease(HF)Heart Failure(MI)Myocardial infarction(MVP)Million Veteran Program(FI)Frailty index(VA)Veterans Administration(CMS)Centers for Medicare and Medicaid Services